Ephedra adverse events
This article was originally published in The Tan Sheet
Executive Summary
Nearly 75% of dietary supplement-related adverse event reports collected during a six-month period in California occurred in patients who ingested ephedrine alkaloid-containing products, a study in the American Journal of Health-System Pharmacy finds. The findings were based on AEs reported to the California Poison Control System between April 2002 and September 2002. Of 480 supplement-related AEs, 353 involved patients who took ephedra products, Cathi Dennehy, University of California, San Francisco, et al., find. The multiple-ingredient products that were "most frequently involved in severe reactions" were Hydroxycut, Metabolife, Xenadrine, Stacker 2 and Yellow Jackets, the authors add. FDA currently is appealing an April 13 Utah federal court decision that overturned the agency's 2004 ban on ephedra for low-dose products...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.